This site is intended for health professionals only

Trial backs Cycloset safety profile


A significant reduction in the risk of diabetic cardiovascular complications has been noted in subjects with type 2 diabetes treated with Cycloset

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine